跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 63,489 条关于
“fms-like tyrosine kinase 3”
全部
63,489
临床试验
35,108
药物
6,314
机构
1,527
资讯
20,540
9个月前
Robust AML Clinical Pipeline Shows Promise with 100+ Companies Developing Novel Therapies
去年
Invivoscribe's LabPMM Secures New York State Approval for Ultra-Sensitive FLT3 ITD MRD Assay in AML
去年
ASCO 2025 Showcases Advances in Myelofibrosis Treatment with Novel JAK Inhibitors and Personalized Approaches
去年
Olverembatinib Shows Promise in TKI-Resistant CML and Ph+ ALL
9个月前
Tyrosine Kinase Inhibitors and Gene Therapies Show Promise for Wet AMD Treatment
2个月前
EGFR-TKIs Pose Highest Cardiovascular Risk Among Tyrosine Kinase Inhibitors, Meta-Analysis Finds
去年
Ruxolitinib Plus TKI Therapy Shows Promise in Chronic Myeloid Leukemia
去年
ESK981 Plus Nivolumab Fails to Show Antitumor Activity in Metastatic Castration-Resistant Prostate Cancer
上个月
Non-Tyrosine Kinase Inhibitors Market to Reach USD 18.7 Billion by 2036, Driven by Biomarker-Linked Oncology Approvals
9个月前
Novel sFlt-1 and Paclitaxel Combination Therapy Shows Synergistic Anti-Tumor Effects in 3D Breast Cancer Models
第 1 页，共 2054 页
上一页
下一页
